| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 10,020 | 10,220 | 13.10. | |
| 10,080 | 10,180 | 13.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.10. | emeis completes the disposal of all its operations in Latin America | 360 | Business Wire | Regulatory News:
Following the completion of the sale of its Brazilian operations, emeis (Paris:EMEIS) has finalized the divestment of all its operating activities in Latin America, for a total... ► Artikel lesen | |
| 30.07. | emeis: Availability of the 2026 Half-Year Financial Report | 720 | Business Wire | Regulatory News:
emeis (Paris:EMEIS):
emeis filed, today, its half-year financial report for the period starting on 1 January 2026 and ending on 30 June 2026, with the French Autorité des... ► Artikel lesen | |
| 30.07. | Emeis H1 2026 slides: occupancy surge drives guidance upgrade | 3 | Investing.com | ||
| 29.07. | emeis: 2026 Half-Year Results | 833 | Business Wire | A first half ahead of expectations: 2026 targets raised Strong growth in operating margins (EBITDAR +18.1%1 and EBITDA +46.3%2and a further increase in occupancy rates (+2.8 pts)
Regulatory... ► Artikel lesen | |
| 03.07. | emeis: Half-Year Review (H1 2026) of the Liquidity Agreement Entered Into With Natixis Oddo BHF | 775 | Business Wire | Regulatory News:
Under the liquidity agreement entrusted by emeis (the "Company") (Paris:EMEIS) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as... ► Artikel lesen | |
| 30.06. | Changes to emeis' Governance: Appointments to the Executive Committee | 1.056 | Business Wire | Jean-Marc Boursier has been appointed Chief Operating Officer (COO) and will be responsible for overseeing operations across all countries Sylvie Brisson has been appointed Group EVP Human... ► Artikel lesen | |
| 23.06. | emeis 2026 General Meeting | 983 | Business Wire | Summary of voting results Olivier Dussopt appointed as Chairman of the Board of Directors Laurent Guillot re-elected as a director and confirmed in his Chief Executive Officer role
Regulatory... ► Artikel lesen | |
| EMEIS Aktie jetzt für 0€ handeln | |||||
| 15.05. | emeis: Documents and Information Related to the Combined General Meeting of 23 June 2026 | 772 | Business Wire | Regulatory News:
The Combined General Meeting of Shareholders of emeis S.A. (the Company ») (Paris:EMEIS) will be held on Tuesday 23 June 2026 at 9:30 a.m. (Paris time), at Maison.A Trocadéro... ► Artikel lesen | |
| 06.05. | emeis: Revenue and Business Activity as of the End of March 2026 | 804 | Business Wire | Recovery momentum continues in the first quarter
Occupancy rates rose across all regions to 89.1% (up 2.1 points on average)
Organic revenue growth of +6.3% in the first quarter
Regulatory News:... ► Artikel lesen | |
| 04.05. | emeis: Availability of the 2025 Universal Registration Document | 857 | Business Wire | Regulatory News:
emeis S.A. (Paris:EMEIS) (the "Company") filed, on 30 April 2026, its 2025 Universal Registration Document with the French Autorité des Marchés Financiers ("AMF").
The 2025... ► Artikel lesen | |
| 27.04. | Emeis promotes Jean-Marc Boursier to deputy CEO role | 1 | Investing.com | ||
| 27.04. | Jean-Marc Boursier wird stellvertretender CEO bei Emeis | 3 | Investing.com Deutsch | ||
| 27.04. | Change to emeis's Governance: Jean-Marc Boursier, Appointed Deputy Chief Executive Officer (Corporate Officer) | 713 | Business Wire | Regulatory News:
Jean-Marc Boursier, previously Deputy Chief Executive Officer (non board), has been appointed Deputy Chief Executive Officer (corporate officer) by the Board of Directors on... ► Artikel lesen | |
| 08.04. | emeis: 2025 Results | 957 | Business Wire | 2025 targets exceeded
Improvements across all financial and operational indicators…
… as well as quality and satisfaction indicators
A favorable trend set to continue in the coming years
… with... ► Artikel lesen | |
| 08.04. | Changes to the Board of Directors of emeis | 762 | Business Wire | Regulatory News:
At their meeting on 7 April 2026, emeis's (Paris:EMEIS) Board of Directors agreed to submit the following nominations for approval at emeis's General Meeting, which will be... ► Artikel lesen | |
| 23.02. | emeis Announces Its Early Exit From the Accelerated Safeguard Plan | 907 | Business Wire | Regulatory News:
emeis (Paris:EMEIS) announces its early exit from the accelerated safeguard plan on February 20, 2026, following the approval of its request by the Nanterre Economic Court.
This... ► Artikel lesen | |
| 17.02. | emeis: Activity and revenue at the end of 2025 (unaudited)1 | 980 | Business Wire | Operational targets exceeded and balance sheet sustainably improved: a turning point for emeis 2025 guidance exceeded
EBITDAR up +19.2% in 2025 on a like-for-like basis
EBITDA up +56.5% on... ► Artikel lesen | |
| 15.01. | TwentyTwo Real Estate und Farallon Capital schließen eine Investition in Höhe von 761 Millionen Euro in Isemia ab, ein mit emeis gegründetes Gesundheitsimmobilienunternehmen mit einem Wert von 1,2 Milliarden Euro | 995 | Business Wire | TwentyTwo Real Estate, ein unabhängiges europäisches Immobilieninvestitions- und -verwaltungsunternehmen, gibt bekannt, dass es gemeinsam mit Farallon Capital eine Investition in Höhe von 761 Millionen... ► Artikel lesen | |
| 14.01. | TwentyTwo Real Estate and Farallon Capital Complete €761 Million Investment in Isemia, a €1.2bn Healthcare Real Estate Company Created With emeis | 869 | Business Wire | TwentyTwo Real Estate, an independent European real estate investment and management firm, announces the completion, alongside Farallon Capital, of a €761 million investment that led to the creation... ► Artikel lesen | |
| 14.01. | emeis Announces the Creation of Isemia, a Real Estate Company Dedicated to Healthcare Real Estate in Europe | 1.090 | Business Wire | Regulatory News:
In accordance with the agreements signed and announced on September 23, 2025, emeis (Paris:EMEIS) announces the creation of Isemia, its healthcare real estate company dedicated... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,800 | -0,47 % | Aktien Frankfurt: Keine Entlastung - Dax rutscht unter 25.000 Punkte | FRANKFURT (dpa-AFX) - Der Dax ist am Donnerstag unter die runde Marke von 25.000 Punkten gerutscht. Eine Stabilisierung nach dem bereits schwachen Vortag schlug damit fehl. Hohe Anleiherenditen und... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,900 | 0,00 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,920 | +0,73 % | Siemens Healthineers stellt Vertrieb von Ultraschallsystemen ein | DJ Siemens Healthineers stellt Vertrieb von Ultraschallsystemen ein
DOW JONES--Siemens Healthineers stellt den Vertrieb von Ultraschallsystemen für die allgemeine Bildgebung zum 12. Oktober 2026... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,840 | +1,05 % | Carl Zeiss Meditec: Abstufung - doch diese Linie hält | ||
| ECKERT & ZIEGLER | 12,370 | +0,24 % | Eckert & Ziegler: Independence gains value: Recent radiopharma transactions highlight the strategic value of EUZ's independent ... | Recent radiopharma acquisitions underline the value of EUZ's core capabilities: independent isotope supply and specialist manufacturing. Strategic and financial investors are acquiring comparable isotope... ► Artikel lesen | |
| INTUITIVE SURGICAL | 376,45 | -0,12 % | ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters | ||
| UNITEDHEALTH | 337,00 | -0,12 % | Ihre wichtigsten Termine: Johnson & Johnson, UnitedHealth, JPMorgan und Wells Fargo legen neue Zahlen vor! | © Foto: Jens Kalaene - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0382221051... ► Artikel lesen | |
| DRAEGERWERK | 115,00 | -0,69 % | Draegerwerk AG & Co. KGaA: Sechsjähriger FDA-Belastungsfaktor beseitigt; US-Monitoring-Geschäft rückt wieder in den Fokus; KAUFEN | Dräger hat ein sechs Jahre währendes regulatorisches Kapitel im US-Patientenmonitoring endlich abgeschlossen. Nach der FDA-Freigabe (Clearance) von Dräger IACS VG8.1 hat die Behörde den 2020 ausgesprochenen... ► Artikel lesen | |
| MEDTRONIC | 83,00 | -0,05 % | Zwei Dividendenwerte im Crash-Rabatt: Warum Cisco und Medtronic jetzt ins Visier konservativer Anleger rücken | Der jüngste Kursrückgang an den Aktienmärkten eröffnet nach Einschätzung eines Beitrags auf Seeking Alpha selektive Einstiegsgelegenheiten bei dividendenstarken Blue Chips. Im Fokus stehen Cisco Systems... ► Artikel lesen | |
| GERRESHEIMER | 29,060 | -0,14 % | Übernahmepoker spitzt sich zu: BASF, Evonik, Gerresheimer, Phenom Resources | Der Übernahmepoker bei BASF und Evonik spitzt sich zu. Inzwischen schaltet sich auch die Politik ein. Die Landesregierung verlangt Arbeitsplatzgarantien. Der NRW-SPD-Fraktionschef äußert sich kritisch... ► Artikel lesen | |
| THERMO FISHER | 594,40 | +0,34 % | Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up? | ||
| TELADOC HEALTH | 5,376 | +0,22 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| STRATEC | 23,450 | 0,00 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,300 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 94,44 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |